Skip to content

Point of Service Diabetes Screening Evaluation

Point of Service Diabetes Screening Evaluation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01669616
Acronym
POSSE
Enrollment
667
Registered
2012-08-21
Start date
2012-08-31
Completion date
2013-01-31
Last updated
2013-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Non-Insulin Dependent

Keywords

Type 2 Diabetes, Adults 18 years and older

Brief summary

The primary objective of the trial is to collect SCOUT DS, random capillary glucose and Hemoglobin A1c measurements from subject 18 years of age or older.

Detailed description

The objectives of this study are to compare the accuracy of SCOUT versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1C-defined dysglycemia.

Interventions

None listed

Sponsors

VeraLight, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older

Exclusion criteria

* Known to be pregnant (self-reported) * Receiving dialysis or known renal compromise * Known to have photosensitivity * Taking medications that fluoresce * Have scars, any tattoos, rashes or other disruption/discoloration on the left volar forearm

Design outcomes

Primary

MeasureTime frame
To compare the accuracy of SCOUT DS versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1c-defined dysglycemia.one week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026